We are pleased to announce that an article by the EU-VIORMED group has been published in CNS Spectrums (2019 Impact Factor: 3.356) on February 5, 2021. This study systematically investigated the available evidence about pharmacological interventions aimed at reducing violence perpetrated by subjects with Schizophrenia Spectrum Disorders (SSDs) in forensic psychiatry.
The review found weak evidence on the efficacy of clozapine, olanzapine, and risperidone in reducing violence in individuals suffering from SSDs. More importantly, it highlighted the paucity of existing studies on pharmacological prescriptions in forensic settings, urgently calling for more research applying more rigorous methods regarding case-definition, outcome measures, sample size, and study design.
Assessing the effectiveness of treatments for people with SSDs in forensic services, the EU-VIORMED project aims to support the harmonization of forensic psychiatric care pathways and treatment patterns across Europe in order to improve the quality of forensic psychiatric care across member states.
The article is available also as online content, please see https://doi.org/10.1017/S1092852921000134.
Reisegger A, Slamanig R, Winkler H, de Girolamo G, Carrà G, Crocamo C, Gosek P, Heitzman J, Salize HJ, Picchioni M, Wancata J. Pharmacological Interventions To Reduce Violence In Patients With Schizophrenia In Forensic Psychiatry. CNS Spectr. 2021 Feb 5:1-33.